Top

Published in:

01-10-2009 | REVIEW

Epilepsy and inborn errors of metabolism in children

Authors: N. I. Wolf, A. García-Cazorla, G. F. Hoffmann

Published in: Journal of Inherited Metabolic Disease | Issue 5/2009

Summary

Epilepsy is a frequent symptom in inborn errors of metabolism, with virtually no specific seizure types or EEG signatures. It is most important to look quickly for those few inborn errors of metabolism in which specific therapies such as supplementation of cofactors or diets can make all the difference. If these investigations remain negative, epilepsy has to be treated with conventional antiepileptic drugs. Still, epilepsy is a potentially treatable symptom of many inborn errors of metabolism, and optimal treatment is of great importance for patients and their families.

Bahi-Buisson N, Kaminska A, Nabbout R, et al (2006a) Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia 47: 380–386. doi:10.1111/j.1528-1167.2006.00432.x CrossRefPubMed

Bahi-Buisson N, Mention K, Leger PL, et al (2006b) Neonatal epilepsy and inborn errors of metabolism. Arch Pediatr 13: 284–292. doi:10.1016/j.arcped.2005.10.024 CrossRefPubMed

Bahi-Buisson N, El Sabbagh S, Soufflet C, et al (2008) Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure 17: 658–664. doi:10.1016/j.seizure.2008.01.005 CrossRefPubMed

de Koning TJ, Klomp LW (2004) Serine-deficiency syndromes. Curr Opin Neurol 17: 197–204. doi:10.1097/00019052-200404000-00019 CrossRefPubMed

de Koning TJ, Klomp LW, van Oppen AC, et al (2004) Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet 364: 2221–2222. doi:10.1016/S0140-6736(04)17596-X CrossRefPubMed

Farrant RD, Walker V, Mills GA, Mellor JM, Langley GJ (2001) Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B₆ deficiency and seizures in hyperprolinemia type II. J Biol Chem 276: 15107–15116. doi:10.1074/jbc.M010860200 CrossRefPubMed

Gallagher RC, Van Hove JL, Scharer G, et al (2009) Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 65: 5550–556.CrossRefPubMed

Hoffmann GF, Schmitt B, Windfuhr M, et al (2007) Pyridoxal 5′-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis 30: 96–99. doi:10.1007/s10545-008-9974-1 CrossRefPubMed

Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A, et al (2006) GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 67: 480–484. doi:10.1212/01.wnl.0000234852.43688.bf CrossRefPubMed

Mills PB, Surtees RA, Champion MP et al (2005) Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet 14: 1077–1086. doi:10.1093/hmg/ddi120 CrossRefPubMed

Mills PB, Struys E, Jakobs C, et al (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12: 307–309. doi:10.1038/nm1366 CrossRefPubMed

Mudd SH, Skovby F, Levy HL, et al (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37: 1–31.PubMedPubMedCentral

Pearl PL, Gibson KM, Acosta MT, et al (2003) Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 60: 1413–1417.CrossRefPubMed

Plecko B, Stockler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C (2000) Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol 48: 121–125. doi:10.1002/1531-8249(200007)48:1<121::AID-ANA20>3.0.CO;2-V CrossRefPubMed

Salbert BA, Pellock JM, Wolf B (1993) Characterization of seizures associated with biotinidase deficiency. Neurology 43: 1351–1355.CrossRefPubMed

Schulze A, Ebinger F, Rating D, Mayatepek E (2001) Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 74: 413–419. doi:10.1006/mgme.2001.3257 CrossRefPubMed

Sedel F, Gourfinkel-An I, Lyon-Caen O, Baulac M, Saudubray JM, Navarro V (2007) Epilepsy and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis 30: 846–854. doi:10.1007/s10545-007-0723-7 CrossRefPubMed

Seidner G, Alvarez MG, Yeh JI, et al (1998) GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 18: 188–191. doi:10.1038/ng0298-188 CrossRefPubMed

Stockler S, Schutz PW, Salomons GS (2007) Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem 46: 149–166. doi:10.1007/978-1-4020-6486-9_8 CrossRefPubMed

Surtees R, Wolf N (2007) Treatable neonatal epilepsy. Arch Dis Child 92: 659–661. doi:10.1136/adc.2007.116913 CrossRefPubMedPubMedCentral

Wolf NI, Bast T, Surtees R (2005) Epilepsy in inborn errors of metabolism. Epileptic Disord 7: 67–81.PubMed

Wolf NI, Rahman S, Schmitt B, et al (2009) Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 50: 1596–1607. doi:10.1111/j.1528-1167.2008.01877.x CrossRefPubMed

Title: Epilepsy and inborn errors of metabolism in children
Authors: N. I. Wolf
A. García-Cazorla
G. F. Hoffmann
Publication date: 01-10-2009
Publisher: Springer Netherlands
Published in: Journal of Inherited Metabolic Disease / Issue 5/2009
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-009-1171-3

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Summary

Please log in to get access to this content

Other articles of this Issue 5/2009

Retinal detachment causing unilateral blindness in a 12-year-old girl with gyrate atrophy

Inborn errors of metabolism and motor disturbances in children

Neurometabolic disorders

Total oxidant-scavenging capacities of plasma from glycogen storage disease type Ia patients as measured by cyclic voltammetry, FRAP and luminescence techniques

Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters

Glyceryl triacetate for Canavan disease: A low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage